Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein

Experimental and Therapeutic Medicine

Volumn 3, Issue 3, 2012, Pages 437-442

  Wu, Di ^a   Guo, Ze ^a   Min, Wei ^a   Zhou, Bingrong ^a   Li, Mingna ^a   Li, Wei ^a   Luo, Dan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Gene silencing; Squamous cell carcinoma; Translationally controlled tumor protein

Indexed keywords

POLYPEPTIDE; POLYPEPTIDE TCTP; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GRADING; CARCINOMA CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MAJOR CLINICAL STUDY; PROTEIN FUNCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; TPTI GENE; UPREGULATION; WESTERN BLOTTING;

EID: 84862931042     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.439     Document Type: Article

References (20)

1. Bohm H, Benndorf R, Gaestel M, Gross B, Nurnberg P, KraftR, Otto A and Bielka H: The growth-related protein P23 of the Ehrlich ascites tumor: translational control, cloning and primary structure. Biochem Int19: 277-286, 1989.
2. Bonnet C, Perret E, Dumont X, Picard A, Caput D and LenaersG: Identification and transcription control of fission yeast genes repressed by an ammonium starvation growth arrest. Yeast 16: 23-33, 2000.
3. MacDonald SM, Rafnar T, Langdon J and Lichtenstein LM: Molecular identification of an IgE-dependent histamine-releasing factor. Science 269: 688-690, 1995.
4. Chen SH, Wu PS, Chou CH, Yan YT, Liu H, Weng SY, et al: A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue or cell type-specific manner. Mol Biol Cell 18: 2525-2532, 2007.
5. Telerman A and Amson R: The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer 9: 206-216, 2009.
6. Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, AmsonR and TelermanA: Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci USA 99: 14976-14981, 2002.
7. Oikawa K, Ohbayashi T, Mimura J, Fujii-Kuriyama Y, TeshimaS, Rokutan K, Mukai K and Kuroda M: Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor. Biochem Biophys Res Commun 290: 984-987, 2002.
8. Sturzenbaum SR, Kille P and Morgan AJ: Identification of heavy metal induced changes in the expression patterns of the translationally controlled tumour protein (TCTP) in the earthworm Lumbricus rubellus1. Biochim Biophys Acta 1398: 294-304, 1998.
9. Vercoutter-Edouart AS, Czeszak X, Crepin M, Lemoine J, Boilly B, Le Bourhis X, Peyrat JP and Hondermarck H: Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res 262: 59-68, 2001.
10. Langdon JM, Vonakis BM and MacDonald SM: Identification of the interaction between the human recombinant histamine releasing factor/translationally controlled tumor protein and elongation factor-1 delta (also known as eElongation factor-1B beta). Biochim Biophys Acta 1688: 232-236, 2004.
11. Li F, Zhang D and Fujise K: Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem 276: 47542-47549, 2001.
12. Amzallag N, Passer BJ, Allanic D, Segura E, Thery C, GoudB, AmsonR and Telerman A: TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J Biol Chem 279: 46104-461012, 2004.
13. Jung J, Kim M, Kim MJ, Kim J, Moon J, LimJS, Kim M and LeeK: Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na,K-ATPase alpha subunit and inhibits the pump activity in HeLa cells. J Biol Chem 279: 49868-49875, 2004.
14. Yang Y, Yang F, Xiong Z, Yan Y, Wang X, Nishino M, et al: An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene 24: 4778-4788, 2005.
15. Liu H, Peng HW, Cheng YS, Yuan HS and Yang-Yen HF: Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol 25: 3117-3126, 2005.
16. Sanchez JC, Schaller D, Ravier F, Golaz O, Jaccoud S, Belet M, et al: Translationally controlled tumor protein: a protein identified in several nontumoral cells including erythrocytes. Electrophoresis 18: 150-155, 1997.
17. Susini L, Besse S, Duflaut D, Lespagnol A, Beekman C, Fiucci G, et al: TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ 15: 1211-1220, 2008.
18. Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, et al: Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Cancer 98: 1444-1456, 2003.
19. Rho SB, Lee JH, Park MS, Byun HJ, Kang S, Seo SS, et al: Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53. FEBS Lett 585: 29-35, 2011.
20. 2+-dependent apoptosis in vivo. Biochem J 408: 181-191, 2007.